Graphite Bio snags $45m Series A
Graphite Bio, a next-generation gene editing company, has secured $45 million in Series A financing.
Graphite Bio, a next-generation gene editing company, has secured $45 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination